Vilin Bio Med Limited
Vilin Bio Med Limited (VILINBIO): company summary
The company's business has improved significantly, with annual revenue rising 185.3% and annual net profit jumping 777.3%.
Vilin Bio Med Limited (VILINBIO) is a micro-cap Healthcare company valued at ₹81 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Vilin Bio Med Limited last traded at ₹53.25, down 2.56% on the day.
- Recent developments
- On 2026-06-30, promoter holding fell by 2.92 percentage points to 56.65%. There are no recent developments reported.
- Financial performance
- The company's business has improved significantly, with annual revenue rising 185.3% and annual net profit jumping 777.3%. The latest quarter saw revenue surge 215.9% and net profit explode 1680.0% compared to the same quarter a year earlier. The net profit margin widened 3.1 percentage points to 4.6%, while return on equity and return on capital employed stood at 6.8% and 10.2% respectively.
- Valuation multiples
- The stock trades at 38.9 times earnings, a premium to the Healthcare median of 32.0, 3.17 times book value.
- Things to watch
- The stock is 7.3% below its 52-week high. The company is not paying out dividend despite reporting repeated profits.
- Where it stands
- The company has delivered strong growth in both revenue and net profit, with the latest quarter showing a dramatic increase. Promoter holding has decreased slightly, and the stock is trading below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (10.0) and momentum (7.5), but held back by valuation (0.9). Growth looks strong at 10.0, but that is offset by valuation at 0.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 74% a year
- Low leverage — D/E 0.01
- Revenue compounding 30% a year
- Valuation is weak (0.9/10)
- Small ₹81 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Vilin Bio Med Limited’s valuation
Free deep-dive tools · no sign-up
Vilin Bio Med Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Vilin Bio Med Limited with peers
Related tools & concepts
Value Vilin Bio Med Limited with the ratios and calculators DocStoX uses in its analysis.

